13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)

1

NAME OF REPORTING PERSON

BEHZAD AGHAZADEH

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3

SEC USE ONLY

4

SOURCE OF FUNDS

AF

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

16,939,461 shares of Common Stock (including options
to purchase 875,000 shares of Common Stock)

22,500 shares of Common Stock underlying director stock options

8

SHARED VOTING POWER

-0-

9

SOLE DISPOSITIVE POWER

16,939,461 shares of Common Stock (including options
to purchase 875,000 shares of Common Stock)

22,500 shares of Common Stock underlying director stock options

10

SHARED DISPOSITIVE POWER

-0-

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

16,939,461 shares of Common Stock (including options
to purchase 875,000 shares of Common Stock)

22,500 shares of Common Stock underlying director stock options

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

11.16%

14

TYPE OF REPORTING PERSON

IN

13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)

Published on November 20, 2017 at 2:44 pm by Insider Monkey Staff in Hedge Funds

Page 3 of 7 – SEC Filing

Follow Immunomedics Inc (NASDAQ:IMMU)

Follow Immunomedics Inc (NASDAQ:IMMU)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff

1	NAME OF REPORTING PERSON BEHZAD AGHAZADEH
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS AF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)		¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:	7	SOLE VOTING POWER 16,939,461 shares of Common Stock (including options to purchase 875,000 shares of Common Stock) 22,500 shares of Common Stock underlying director stock options
	8	SHARED VOTING POWER -0-
	9	SOLE DISPOSITIVE POWER 16,939,461 shares of Common Stock (including options to purchase 875,000 shares of Common Stock) 22,500 shares of Common Stock underlying director stock options
	10	SHARED DISPOSITIVE POWER -0-
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 16,939,461 shares of Common Stock (including options to purchase 875,000 shares of Common Stock) 22,500 shares of Common Stock underlying director stock options
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES			¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 11.16%
14	TYPE OF REPORTING PERSON IN